Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RM-191A by RR MedSciences for Neuropathic Pain (Neuralgia): Likelihood of Approval
RM-191A is under clinical development by RR MedSciences and currently in Phase II for Neuropathic Pain (Neuralgia). According to GlobalData,...